Literature DB >> 21138828

Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns.

J Wells Logan1, T Michael O'Shea, Elizabeth N Allred, Matthew M Laughon, Carl L Bose, Olaf Dammann, Daniel G Batton, Stephen C Engelke, Alan Leviton.   

Abstract

OBJECTIVES: To evaluate in extremely low gestational age newborns, relationships between indicators of hypotension during the first 24 postnatal hours and developmental delay at 24 months of age.
METHODS: The 945 infants in this prospective study were born at <28 weeks, were assessed for three indicators of hypotension in the first 24 postnatal hours, and were evaluated with the Bayley Mental Development Index (MDI) and Psychomotor Development Index (PDI) at 24 months corrected age. Indicators of hypotension included: (1) mean arterial pressure in the lowest quartile for gestational age; (2) treatment with a vasopressor; and (3) blood pressure lability, defined as the upper quartile for the difference between the lowest and highest mean arterial pressure. Logistic regression was used to evaluate relationships between hypotension and developmental outcomes, adjusting for potential confounders.
RESULTS: 78% of infants in this cohort received volume expansion or vasopressor; all who received a vasopressor were treated with volume expansion. 26% had an MDI <70 and 32% had a PDI <70. Low MDI and PDI were associated with low gestational age, which in turn, was associated with receipt of vasopressor treatment. Blood pressure in the lowest quartile for gestational age was associated with vasopressor treatment and labile blood pressure. After adjusting for potential confounders, none of the indicators of hypotension were associated with MDI <70 or PDI <70.
CONCLUSIONS: In this large cohort of extremely low gestational age newborns, we found little evidence that early postnatal hypotension indicators are associated with developmental delay at 24 months corrected gestational age.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21138828      PMCID: PMC5452075          DOI: 10.1136/adc.2010.183335

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  65 in total

1.  Colloid infusion in the perinatal period and abnormal neurodevelopmental outcome in very low birth weight infants.

Authors:  Anne Greenough; Paul Cheeseman; Vasiliki Kavvadia; Gabriel Dimitriou; Margaret Morton
Journal:  Eur J Pediatr       Date:  2002-04-16       Impact factor: 3.183

2.  Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors:  Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

3.  Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data.

Authors:  Melissa D Begg; Michael K Parides
Journal:  Stat Med       Date:  2003-08-30       Impact factor: 2.373

Review 4.  Autoregulation of cerebral blood flow in newborn babies.

Authors:  Gorm Greisen
Journal:  Early Hum Dev       Date:  2005-05       Impact factor: 2.079

5.  Confounding by indication.

Authors:  A M Walker
Journal:  Epidemiology       Date:  1996-07       Impact factor: 4.822

6.  Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks' gestation.

Authors:  C M Salafia; V K Minior; T S Rosenkrantz; J C Pezzullo; E J Popek; W Cusick; A M Vintzileos
Journal:  Am J Perinatol       Date:  1995-11       Impact factor: 1.862

7.  Perinatal risk factors for the development of extensive cystic leukomalacia.

Authors:  L S de Vries; R Regev; L M Dubowitz; A Whitelaw; V R Aber
Journal:  Am J Dis Child       Date:  1988-07

8.  Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants.

Authors:  Janet S Soul; Peter E Hammer; Miles Tsuji; J Philip Saul; Haim Bassan; Catherine Limperopoulos; Donald N Disalvo; Marianne Moore; Patricia Akins; Steven Ringer; Joseph J Volpe; Felicia Trachtenberg; Adré J du Plessis
Journal:  Pediatr Res       Date:  2007-04       Impact factor: 3.756

9.  Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification.

Authors:  T F McElrath; J L Hecht; O Dammann; K Boggess; A Onderdonk; G Markenson; M Harper; E Delpapa; E N Allred; A Leviton
Journal:  Am J Epidemiol       Date:  2008-08-27       Impact factor: 4.897

10.  Blood pressure, anti-hypotensive therapy, and neurodevelopment in extremely preterm infants.

Authors:  Beau Batton; Xiobei Zhu; Jonathan Fanaroff; H Lester Kirchner; Sheila Berlin; Deanne Wilson-Costello; Michele Walsh
Journal:  J Pediatr       Date:  2008-11-20       Impact factor: 4.406

View more
  17 in total

1.  Accuracy of non-invasive blood pressure monitoring in very preterm infants.

Authors:  Kai König; Dan M Casalaz; Emily J Burke; Andrew Watkins
Journal:  Intensive Care Med       Date:  2012-03-06       Impact factor: 17.440

2.  Use of antihypotensive therapies in extremely preterm infants.

Authors:  Beau Batton; Lei Li; Nancy S Newman; Abhik Das; Kristi L Watterberg; Bradley A Yoder; Roger G Faix; Matthew M Laughon; Barbara J Stoll; Krisa P Van Meurs; Waldemar A Carlo; Brenda B Poindexter; Edward F Bell; Pablo J Sánchez; Richard A Ehrenkranz; Ronald N Goldberg; Abbot R Laptook; Kathleen A Kennedy; Ivan D Frantz; Seetha Shankaran; Kurt Schibler; Rosemary D Higgins; Michele C Walsh
Journal:  Pediatrics       Date:  2013-05-06       Impact factor: 7.124

3.  Antenatal and neonatal antecedents of learning limitations in 10-year old children born extremely preterm.

Authors:  Alan Leviton; Robert M Joseph; Elizabeth N Allred; T Michael O'Shea; Karl K C Kuban
Journal:  Early Hum Dev       Date:  2018-02-07       Impact factor: 2.079

4.  Antenatal and Neonatal Antecedents of Executive Dysfunctions in Extremely Preterm Children.

Authors:  Alan Leviton; Robert M Joseph; Elizabeth N Allred; T Michael O'Shea; H Gerry Taylor; Karl K C Kuban
Journal:  J Child Neurol       Date:  2018-01-11       Impact factor: 1.987

5.  Feasibility study of early blood pressure management in extremely preterm infants.

Authors:  Beau J Batton; Lei Li; Nancy S Newman; Abhik Das; Kristi L Watterberg; Bradley A Yoder; Roger G Faix; Matthew M Laughon; Krisa P Van Meurs; Waldemar A Carlo; Rosemary D Higgins; Michele C Walsh
Journal:  J Pediatr       Date:  2012-02-14       Impact factor: 4.406

6.  Newborn blood gas derangements of children born extremely preterm and neurocognitive dysfunctions at age 10 years.

Authors:  Alan Leviton; Elizabeth N Allred; Robert M Joseph; T Michael O'Shea; Karl C K Kuban
Journal:  Respir Physiol Neurobiol       Date:  2017-04-07       Impact factor: 1.931

7.  Inotropes do not increase cardiac output or cerebral blood flow in preterm piglets.

Authors:  Yvonne A Eiby; Nicole Y Shrimpton; Ian M R Wright; Eugenie R Lumbers; Paul B Colditz; Greg J Duncombe; Barbara E Lingwood
Journal:  Pediatr Res       Date:  2016-08-04       Impact factor: 3.756

8.  Early blood pressure, antihypotensive therapy and outcomes at 18-22 months' corrected age in extremely preterm infants.

Authors:  Beau Batton; Lei Li; Nancy S Newman; Abhik Das; Kristi L Watterberg; Bradley A Yoder; Roger G Faix; Matthew M Laughon; Barbara J Stoll; Rosemary D Higgins; Michele C Walsh
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2015-11-13       Impact factor: 5.747

9.  Risk Factors of Mechanical Ventilation in Premature Infants During Hospitalization.

Authors:  Guang Yue; Jun Wang; Huaying Li; Biao Li; Rong Ju
Journal:  Ther Clin Risk Manag       Date:  2021-07-30       Impact factor: 2.423

10.  A pig model of the preterm neonate: anthropometric and physiological characteristics.

Authors:  Yvonne A Eiby; Layne L Wright; Viskasari P Kalanjati; Stephanie M Miller; Stella T Bjorkman; Helen L Keates; Eugenie R Lumbers; Paul B Colditz; Barbara E Lingwood
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.